AcuCort is a biotechnology company. The company has developed and commercializes the drug Zeqmelit, which is an oral film based on the cortisone substance dexamethasone, for quick availability and relief in, for instance, severe and acute allergic reactions. Zeqmelit is approved in Sweden, Denmark and Norway. The goal is global commercialization in the EU, USA and in selected key markets via licensees and distributors. The company has its headquarters in Lund.

Quotes for AcuCort AB

Right Now

+/-
-0.011
%
-2,89%
Latest
0.369
High
0.387
Low
0.348
Volume
722 256
Turnover (SEK)
254 132
Market Value (MSEK)
11,5
Time (Latest trade)

Board

CEO

  • Jonas Jönmark

Chairperson of the Board

  • Ebba Fåhraeus

Board

  • Alexandra Johnsson
  • Anna Eriksrud
  • Göran Tornling
  • Monica Wallter

Videos

Largest Owners

Name Capital % Votes % Date
Aqilion AB 16,20 16,20 2023-09-27
Avanza Pension 8,80 8,80 2023-09-27
Erik Fällström via bolag 7,34 7,34 2023-09-27
Zoya Invest AB 5,75 5,75 2023-09-27
Berne Gilbert Okdah 2,83 2,83 2023-09-27
Nordnet Pensionsförsäkring 2,09 2,09 2023-09-27
Sparbanksstiftelser – Ej Sparbanksgruppen 1,60 1,60 2023-09-27
Alexander Svensson 1,60 1,60 2023-09-27
Göran Ofsén 1,60 1,60 2023-09-27
Carin Lindeberg 1,28 1,28 2023-09-27
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream